Chiome Bioscience Revises Forecast Amid Financial Challenges
Company Announcements

Chiome Bioscience Revises Forecast Amid Financial Challenges

Chiome Bioscience Inc. (JP:4583) has released an update.

Chiome Bioscience Inc. reported a decline in net sales to 422 million yen for the nine months ending September 2024, with continued losses in operating and net incomes. Despite challenging financial results, the company revised its forecast for the drug discovery support business to 720 million yen, reflecting a more optimistic outlook for this segment.

For further insights into JP:4583 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App